Lawyers

• 

  Who's Defending Your Patent Rights? The Active Role of a Patent Lawyer, What Do They Do

  Illuminate your understanding of patent defense. A closer look at the patent attorney's vital role will underscore why professional legal help is key to your patent's success.

• IBM Quantum Computing is Now Available for Industry Partners; Computing Breakthrough is Expected

  The ‘Big Blue’ brings its quantum computing research to production for the next generation of computing on Monday.

• IBM Gets the Patent for ‘Out of the Office’ Email Responder

  U.S. Patent and Trademark Office granted IBM the patent for “Out of the Office” email auto responder, in the year 2017.

• Patent Troll Eolas Technologies Continue Its Lawsuit Against Google in California

  Eolas Technologies will continue its patent lawsuit against Google from Texas to California after the Court of Appeals granted the writ of mandamus.

• Judge Sanctions Cooley Law Firm and Invincea For Late Delivery of Important Document

  Judge in Virginia federal court has imposed sanction to Cooley law firm and its client Invincea cyber security company in a patent infringement case.

• Apple to Pay $24.9 Million to Settle Patent Lawsuit Against Siri

  Apple will pay $24.9 million to Dynamic Advances, which claim that Apple’s Siri violate a patent licensed to the company. The settlement was made one month after the case is due to trial.

• VirnetX tells jury Apple should pay $532M over patent infringement

  In a jury trial, patent holding firm VirnetX said Apple should pay $532 million for using VirnetX's patented technology in Apple's FaceTime and VPN.

• IPhone 7 Rumors: Could it have a wrap-around screen, better speakers but minus the 3.5mm headphone jack?

  Iphone 7 new features is said to include a wrap-around screen, better speakers, but not a 3.5mm headphone jack.

• Cisco gets big patent win over wifi technology

  Cisco Systems wins a patent dispute against an Israeli company, Commil USA LLC. The Federal Court has finally put an end to the suit and put a verdict in favor of Cisco.

• Apple loses patent lawsuit to University of Wisconsin, faces hefty damages

  Apple Inc could be facing up to $862 million in damages after a U.S. jury on Tuesday found the iPhone maker used technology owned by the University of Wisconsin-Madison's licensing arm without permission in chips found in many of its most popular devices.

• Microsoft, Google stand down in patent battles

  Microsoft Corp (MSFT.O) and Google Inc (GOOGL.O) have agreed to bury all patent infringement litigation against each other, the companies announced on Wednesday, settling 18 cases in the United States and Germany.

• India rejects patent on Pfizer's arthritis drug

  India has again denied Pfizer Inc(PFE.N) a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a multinational drugmaker seeking to enforce its intellectual property rights in the country.

• Gay marriage aside, business cases dominate U.S. high court docket

  Gay marriage may be the most anticipated issue heading for the U.S. Supreme Court, but the justices also must tackle a host of business cases as they convene for their new term, including a patent battle involving Teva Pharmaceutical Industries Ltd.

• WiLan says loses LTE patent case against Apple

  Canadian patent licensing company WiLan Inc (WIN.TO) on Wednesday said a U.S. judge had ruled in favor of Apple Inc (AAPL.O) in a litigation case against it.

• ARM CEO defends chip technology connected to Nvidia legal fight

  ARM Holdings Chief Executive Officer Simon Segars on Monday defended the British chip designer's smartphone graphics technology connected to a patent suit by Nvidia Corp against Samsung Electronics and Qualcomm.

• Sony prevails in patent suit battle with defense contractor L-3

  A federal judge has ruled in favor of Sony Corp in a long-running case, overturning a jury verdict for L-3 Communications Corp [LLLCO.UL] and invalidating several parts of an image sensor patent held by the defense contractor.

• Teva Pharma Reaches Settlement with Pfizer over Celebrex Patent

  In a statement, Pfizer confirms a settlement agreement with Teva as to the manufacture of a generic version of Celebrex but maintains the validity of its existing patent over the drug.